Analysis Bastide Le Confort Médical SA (0IP1)
6/1/2024
Analysis of Bastide Le Confort Médical SA (0IP1)
Bastide Le Confort Médical SA is showing some interesting trends based on the provided data:1. Price Movement: The closing prices have been fluctuating, with the most recent closing price at 26.94852. The stock has shown some volatility in the past few days, with highs and lows ranging from 26.15000 to 27.00000.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) is currently at 80.59205, indicating that the stock may be overbought.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) is positive at 1.86759, with the MACD line above the signal line, suggesting a bullish trend.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, indicating a positive momentum.
3. Overall, based on the technical indicators and price movements, Bastide Le Confort Médical SA seems to be in a bullish phase. However, investors should be cautious of the overbought RSI levels and monitor the stock closely for any potential reversals in the trend.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for the quarter ending on October 31, 2024, were not provided on time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic 🧠
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio, while the forward and trailing P/E ratios are moderate. The company's market capitalization and enterprise value are substantial, with reasonable price-to-sales and enterprise-to-EBITDA ratios.
The stock price summary includes beta, moving averages, and the range of prices over the past year. Dividends and splits information shows the company's dividend history, payout ratio, and dividend yield metrics.
Income statement 💸
These are the revenues. Draw conclusions.Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate slightly each year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2023 at $73,812,000,000.
Overall, the company's assets and liabilities have been increasing over the years, with fluctuations in shareholders' equity.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
4. Investing activities reflect significant amounts spent on the sale and purchase of investments, with fluctuations in capital expenditures.
5. The end cash position has varied over the years, reaching its highest value in 2020 and its lowest in 2022.
6. Interest paid and income tax paid figures show variations, impacting the company's overall cash flow position.
7. The company has been consistent in paying dividends to its shareholders, with fluctuations in the amounts over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a growth trajectory from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The estimated average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past but is expected to see a slightly lower growth rate in the coming years, although still positive. It's important to note that these are analyst estimates and actual performance may vary.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57. It appears that the analysts are generally optimistic about the future price of the security, with the average and median estimates both higher than the current price.MACD of 0IP1
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
